Devices/Safety Alert·openFDA/device

HeartStart MRx monitor/defib (Philips North America LLC) — Malfunction

MediumPublished Aug 31, 2026· AI-analyzed Sep 9, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

A malfunction event was reported regarding the HeartStart MRx monitor/defibrillator manufactured by Philips North America LLC. The source identifies the event as a device malfunction but does not detail the specific failure mechanism or patient impact.

Who it affects

Philips North America LLC, healthcare providers utilizing the HeartStart MRx monitor/defibrillator, and biomedical engineering departments responsible for the maintenance of these devices.

Why it matters

While the source provides limited detail regarding the nature of the malfunction, reporting of this type typically triggers internal CAPA (Corrective and Preventive Action) reviews to determine if the failure represents a systemic issue. For regulatory professionals, this serves as a signal to monitor for potential subsequent field safety notices or recalls if the malfunction is found to be recurring or inherent to the device design.

Practical takeaway

Regulatory and QA teams should ensure that post-market surveillance systems are actively capturing and trending malfunction data for this device class. Facilities utilizing these monitors should verify that their equipment maintenance protocols align with the manufacturer’s latest service requirements.

FDA source material

Event type: Malfunction. Device: HeartStart MRx monitor/defib by Philips North America LLC.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.